Post-approval studies (Phase 4)UnknownNCT04350684What this trial is testingUmifenovir in Hospitalized COVID-19 PatientsWho this might be right forCOVID-19 Shahid Beheshti University of Medical Sciences 40
Testing effectiveness (Phase 2)Study completedNCT04481685What this trial is testingA Trial of Aclaris Therapeutics, Inc. (ATI)-450 in Patients With Moderate-severe Novel Coronavirus Disease 2019 (COVID-19)Who this might be right forCovid19 University of Kansas Medical Center 20
Not applicableStudy completedNCT04681001What this trial is testingProphylactic Treatment With Carragelose Nasal Spary to Prevent SARS-CoV-2, COVID-19, Infections in Health Care WorkersWho this might be right forRespiratory Viral InfectionCommon ColdSevere Acute Respiratory Syndrome (SARS) Pneumonia+2 more Marinomed Biotech AG 300
Testing effectiveness (Phase 2)Ended earlyNCT04365101What this trial is testingNatural Killer Cell (CYNK-001) Infusions in Adults With COVID-19Who this might be right forCoronavirusCoronavirus InfectionSevere Acute Respiratory Syndrome Coronavirus 2+17 more Celularity Incorporated 7
Not applicableUnknownNCT04834102What this trial is testingCOVID-19 Induced Telogen EffluviumWho this might be right forCovid19Telogen EffluviumSARS-CoV Infection+1 more Istanbul Medeniyet University 200
Early research (Phase 1)Study completedNCT04519437What this trial is testingStudy Assessing the Safety, Tolerability, Pharmacokinetics, and Immunogenicity of Repeated Subcutaneous Doses of Anti-Spike (S) SARS-CoV-2 Monoclonal Antibodies (REGN10933+REGN10987) in Adult Volunteers as Related to COVID-19Who this might be right forHealthyChronic Stable Illness Regeneron Pharmaceuticals 974
Testing effectiveness (Phase 2)Ended earlyNCT04498377What this trial is testingStudy of F-652 (IL-22:IgG2 Fusion Protein) in Patients With Moderate to Severe COVID-19Who this might be right forCovid19 EVIVE Biotechnology 1
Testing effectiveness (Phase 2)Study completedNCT04466098What this trial is testingMultiple Dosing of Mesenchymal Stromal Cells in Patients With ARDS (COVID-19)Who this might be right forAcute Respiratory Distress SyndromeARDS (Moderate or Severe)COVID-19 Pneumonia Masonic Cancer Center, University of Minnesota 8
Testing effectiveness (Phase 2)UnknownNCT04595136What this trial is testingStudy to Evaluate the Efficacy of COVID19-0001-USR in Patients With Mild/or Moderate COVID-19 Infection in OutpatientWho this might be right forSARS-CoV-2 Infection United Medical Specialties 60
Not applicableStudy completedNCT04403009What this trial is testingThe Clinical Difference Between the Nonfatal Patients and the Fatal Patients With Severe COVID-19Who this might be right forCoronavirus Disease 2019Character of the Severe Patients The First Affiliated Hospital of Guangzhou Medical University 100
Large-scale testing (Phase 3)Study completedNCT05543616What this trial is testingLearn About Variant-Adapted COVID-19 RNA Vaccine Candidate(s) in Healthy ChildrenWho this might be right forSARS-CoV-2 VirusSevere Acute Respiratory Syndrome Coronavirus 2COVID-19 BioNTech SE 4,338
Testing effectiveness (Phase 2)Study completedNCT04380701What this trial is testingA Trial Investigating the Safety and Effects of Four BNT162 Vaccines Against COVID-19 in Healthy and Immunocompromised AdultsWho this might be right forInfections, RespiratoryVirus DiseasesInfection Viral+3 more BioNTech SE 512
Not applicableStudy completedNCT04516928What this trial is testingStudy of SARS-CoV2 Virus (COVID-19) Seroprevalence Among Lyon-Bron Military Health Schools PersonnelWho this might be right forSARS-CoV InfectionCovid19 Direction Centrale du Service de Santé des Armées 392
Not applicableStudy completedNCT04912700What this trial is testingThe Impact of Vaccination on Severity of Illness in COVID-19Who this might be right forCovid19 Corewell Health East 11,834
Large-scale testing (Phase 3)Study completedNCT04501978What this trial is testingACTIV-3: Therapeutics for Inpatients With COVID-19Who this might be right forCovid19 National Institute of Allergy and Infectious Diseases (NIAID) 2,753
Testing effectiveness (Phase 2)Ended earlyNCT04511650What this trial is testingEvaluation of the Safety and Efficacy of Razuprotafib in Hospitalized Subjects With Coronavirus Disease 2019Who this might be right forCOVID-19Acute Respiratory Distress Syndrome (ARDS) EyePoint Pharmaceuticals, Inc. 31
Post-approval studies (Phase 4)Active Not RecruitingNCT07266558What this trial is testingEvaluate the Efficacy and Safety of mRNA-1283 and mRNA-1273 in Participants 50 to 64 Years of Age Without High-Risk Conditions for Severe Coronavirus Disease 2019 (COVID-19)Who this might be right forSARS-CoV-2 ModernaTX, Inc. 30,000
Not applicableStudy completedNCT04367740What this trial is testingScreenNC, a Study to Determine the Number of Asymptomatic Individuals Who Have Antibodies to the Virus That Causes COVID-19Who this might be right forAsymptomatic ConditionInfection ViralCoronavirus Infections+5 more University of North Carolina, Chapel Hill 6,313
Testing effectiveness (Phase 2)Ended earlyNCT04342897What this trial is testingLY3127804 in Participants With COVID-19Who this might be right forCOVID-19Pneumonia Eli Lilly and Company 95
Not applicableUnknownNCT05767853What this trial is testingMultiparametric Assessment of Peripheral Blood and Tissue Myeloid Cells. Phenotype for Precision Medicine in Patients With SARS-Cov-2 InfectionWho this might be right forCOVID-19 Pneumonia Fondazione Policlinico Universitario Agostino Gemelli IRCCS 30